T80.810D Extravasation of vesicant antineoplastic chemotherapy, subsequent encounter

Name of the Condition

• Extravasation of Vesicant Antineoplastic Chemotherapy, Subsequent Encounter

Summary

This condition occurs when a vesicant chemotherapy drug leaks from a blood vessel into surrounding tissues during a subsequent encounter. Vesicants are highly irritating drugs that can cause severe tissue damage when not administered properly.

Causes

Most commonly caused during intravenous (IV) administration of highly concentrated chemotherapy drugs where the drug leaks out of the vein.

Risk Factors

• High-risk factors include small veins, fragile veins often found in elderly patients, repeated cannulations, prior damage to veins from previous treatments, and inexperienced healthcare personnel administering chemotherapy.

Symptoms

• Patients may experience pain, swelling, redness, or a burning sensation at the site of the IV injection. If severe, there might be tissue necrosis leading to ulceration.

Diagnosis

Diagnosis is primarily based on clinical examination and patient history. Imaging tests such as ultrasound might be used to assess the extent of the leakage and damage.

Treatment Options

• Immediate cessation of the infusion of the drug.
• Application of ice or heat packs, depending on the protocol for the specific drug.
• Administration of antidotes or medications to neutralize the drug.
• Surgical intervention may be required in severe cases.

Prognosis and Follow-Up

Prognosis depends on the severity of the extravasation and the promptness of treatment. Follow-up care may involve monitoring for tissue healing, pain management, and addressing any long-term complications.

Complications

• Severe tissue damage, including necrosis and ulceration.
• Infection at the site of extravasation.
• Limited mobility due to pain or tissue damage.
• Delayed wound healing.

Lifestyle & Prevention

• Ensure proper vein selection and secure IV access during chemotherapy administration.
• Use trained personnel for drug administration.
• Monitor the IV site closely during infusion.
• Educate patients on reporting immediate symptoms like pain or swelling.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden pain, swelling, redness, or burning at the IV site during or after chemotherapy. Prompt evaluation can prevent severe tissue damage.

Tips for Medical Coders

• Use this code for subsequent encounters related to extravasation of vesicant antineoplastic chemotherapy.
• Document the clinical findings, treatment provided, and any follow-up care to support accurate coding.
• Ensure the encounter is classified as "subsequent" based on the timing and nature of the care provided.